Osteoporosis Drug Evista Approved  to Cut Risk of Breast Cancer
609109
FRIDAY, Sept. 14 (HealthDay News) -- The Eli Lilly drug Evista (raloxifene) has been approved by the U.S. Food and Drug Administration to reduce the risk of invasive breast cancer among postmenopausal at high risk for the disease and among postmenopausal women with osteoporosis.
167586
SAN ANTONIO -- A newer drug clearly outperforms tamoxifen at preventing breast cancer from returning and should become the first-choice treatment for most women who have had the disease, doctors are reporting.
377151
Drugs used to treat high blood pressure are also linked with a reduced risk of bone fractures, research shows.
399636
A drug currently used against advanced breast cancer may provide better protection against recurrence or spreading than standard medication for post-menopausal women who have been treated for early forms of the disease, Swiss pharmaceutical giant Novartis AG and independent researchers said Wednesday.
642497
NEW YORK  - Treatment with a drug used to  combat the bone-thinning disease osteoporosis appears to reduce  the occurrence of osteoarthritis-related damage in the knee,  according to a new report.
486113
For the first time, an osteoporosis drug has reduced deaths and prevented new fractures in elderly patients with broken hips, according to new research.
31407
A new type of breast cancer drug is  superior to the old standard, tamoxifen, in older women and  should now be the first drug used to treat the cancer, U.S. and  British researchers said on Wednesday.
556150
TUESDAY, Jan. 30 (HealthDay News) -- A compound designed to block growth hormone, coupled with a standard chemotherapy drug, successfully treated human breast cancer in mice.
559315
Novartis AG said on Wednesday that its breast cancer pill Femara is more effective than the current standard treatment tamoxifen in reducing the risk that the cancer will return to older women after surgery.
156055
TUESDAY, Feb. 13 (HealthDay News) -- Switching to newer breast cancer drugs, called aromatase inhibitors, after two to three years of treatment with tamoxifen may extend disease-free survival and slightly reduce the risk of death in women who've been treated for early stage disease, an international study finds.
195956
A newer drug prevented far more breast cancers from recurring in older women than the old standby tamoxifen and with far fewer side effects, doctors said Wednesday, citing a new study.
448229
A drug used to treat bone marrow  cancer may also help treat osteoporosis by stimulating stem  cells, U.S. researchers reported on Friday.
769714
A drug called anastrozole is better at preventing relapses among certain breast cancer patients than tamoxifen, the current standard treatment, research presented at a medical conference Wednesday shows.
264861
Osteoporosis drug could give the company its next big winner.
56445
WEDNESDAY, Jan. 16 (HealthDay News) -- A new genetic test that helps assess the risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer has been approved by the U.S. Food and Drug Administration.
52993
NEW YORK  - A drug used to restore the  strength of brittle bones by reducing the process of bone  resorption has been shown to benefit women 80 years of age or  older.
295591
A drug used to treat bone marrow cancer may also help treat osteoporosis by stimulating stem cells, U.S. researchers reported on Friday.